European Committee

Sep 19, 2024 | medicalxpress.com | European Committee

This article has been reviewed according to Science X's editorial process and policies . Editors have highlighted the following attributes while ensuring the content's credibility:A study presented at ECTRIMS 2024 has identified critical biomarkers that can predict disability worsening in multiple sclerosis (MS). The breakthrough research has the potential to transform treatment strategies for millions of MS patients worldwide, paving the way for more personalized and effective treatment plans.

Sep 18, 2024 | medicalxpress.com | European Committee

This article has been reviewed according to Science X's editorial process and policies . Editors have highlighted the following attributes while ensuring the content's credibility:A study has revealed significant therapeutic inertia in the treatment of women with multiple sclerosis (MS), highlighting gender disparities that could impact long-term health outcomes for women of childbearing age.

Sep 17, 2024 | medicalxpress.com | European Committee

This article has been reviewed according to Science X's editorial process and policies . Editors have highlighted the following attributes while ensuring the content's credibility:A study has uncovered novel ancestry-specific genetic variants linked to multiple sclerosis (MS), offering new insights that could reshape treatment approaches for diverse populations affected by the disease.

Sep 17, 2024 | medicalxpress.com | European Committee

This article has been reviewed according to Science X's editorial process and policies . Editors have highlighted the following attributes while ensuring the content's credibility:New research presented today at European Committee for Treatment and Research in Multiple Sclerosis 2024 reveals that initiating monoclonal antibody therapy during childhood, rather than delaying treatment until early adulthood, significantly reduces long-term disability in multiple sclerosis (MS) patients.

Feb 29, 2024 | sciencedirect.com | European Committee |European Medicines Agency

Primary antimicrobial prophylaxis in surgical procedures, defined as prevention of an initial infection, is a common practice with the objective to prevent surgical site infections (SSI), both in human and veterinary medicine (Whittem et al., 1999; Hauser et al., 2006; Bratzler et al., 2013; Xu et al., 2015).